Experimentica

A global ophthalmic contract research organization headquartered in Kuopio, Finland.

[NeoVasculoStop @NeoVasculo]

Great achievement in neovascularization research by our Consortium Partner, @experimentica !
#Experimentica #ExperimenticaScience #Retinopathy #AI

[Experimentica @experimentica]

Jeff Jamison and Guillaume Demarne will be in Boston next week for the 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit!

Book a meeting with us there
https://t.co/aplE0JfEbc

Not attending? Book a later Teams call
https://t.co/rOJ2ptGuWX

#wetAMD #DiabeticRetinopathy

[Experimentica @experimentica]

Meet us at BioFIT in Marseille, France for our last meeting of 2023! Let's discuss about your preclinical ocular drug development programs and needs for 2024.

Not attending BioFIT?. Book a Teams meeting
https://t.co/nnT63wbjdI

#Experimentica #Event
https://t.co/uOFCB5OpvH

[Experimentica @experimentica]

[PRESENTATION] Animal Models for Dry AMD Therapeutic Development | 4th Dry AMD Drug Development Summit | Boston, Nov 14-17, 2023

Jeff Jamison, Experimentica’s CDO, shares his take on relevant in vivo models of dry AMD

Program:
https://t.co/phfFMrr6rt

#Experimentica #dryAMD

[Experimentica @experimentica]

[SAVE THE DATE] Join us at 4th Dry AMD Drug Development Summit in Boston, MA, from November 14-17, 2023

Full Program here:
https://t.co/Nh7Ok9p0tU

Not attending? Schedule a Teams meeting with us:
https://t.co/rOJ2ptGuWX

#Experimentica #Event #dryamd

[Experimentica @experimentica]

We want to hear about your preclinical ocular drug developments! Meet with us at Bio-Europe 2023 on Nov 7-8, 2023

Not attending Bio-Europe?. Book a Teams meeting
https://t.co/nnT63wbjdI

#Experimentica #Event
https://t.co/uOFCB5OpvH

[Experimentica @experimentica]

Join us at Eyecelerator 2023 in SF, CA on November 2, 2023. Connect with Giedrius Kalesnykas, Guillaume Demarne, and Jeff Jamison to explore your ocular drug development programs.

Can't make it in person? Let's schedule a Teams meeting
https://t.co/rOJ2ptGuWX.

#Eyecelerator2023

[Experimentica @experimentica]

[CONFERENCE] 4th Annual Gene Therapy for Ophthalmic Disorders conference, Boston, October 4-5, 2023

Guillaume Demarne and Jeff Jamison will meet with you to discuss your ocular GTx programs.

Not attending? Schedule a Teams meeting:
https://t.co/rOJ2ptGuWX

#Experimentica #Event

[Experimentica @experimentica]

[POSTER] Effect of Pertussis toxin and CFA on Meibomian gland function and secretion. Dr. Marianna Bacellar-Galdino will present at ACVO's Conference.

Abstract
https://t.co/8m9upOhBLk

Interest in rabbit MGD? Schedule a meeting
https://t.co/1X0Hm9L03G

#Experimentica #Event

[Experimentica @experimentica]

[CONFERENCE] Experimentica’s Director of Veterinary Ophthalmology will attend ACVO's 54th Annual Scientific Conference in Boston on Sept 20-23, 2023

Program:
https://t.co/RlvAQhOPNr

Not attending ? Schedule an online meeting:
https://t.co/rOJ2ptGuWX

#Experimentica #Event

[Experimentica @experimentica]

[CONFERENCE] Our team is gearing up for Life Sciences Baltics 2023! Meet us in Vilnius and discuss how we can support your preclinical studies in Ophthalmology.

Not attending? Schedule online meeting
https://t.co/rOJ2ptGuWX

#Experimentica #Event

[Experimentica @experimentica]

[EVENT] Experimentica Science Day - Pharmaceutical Drug Delivery: Lessons from Ophthalmology | May 26, 2023, Vilnius, LT.

Programme and free Registration
https://t.co/lqNF0k0VdU

#Experimentica #Event #10years

[Experimentica @experimentica]

[ABSTRACT] Recombinant human PRG4 alleviates signs of allergic conjunctivitis in vivo.

Authors: Iqbal S, et al.

All ARVO 2023 abstracts:
https://t.co/7FiTU1lfk0

#Experimentica #Event

[Experimentica @experimentica]

[ABSTRACT] Subconjunctival administration of Aflibercept protects against neovascularization in the mouse CNV model.

Authors: Cerrada-Gimenez M, et al.

All ARVO 2023 abstracts:
https://t.co/7FiTU1lfk0

#Experimentica #Event

[Experimentica @experimentica]

[ABSTRACT] Aflibercept exerts structural protection against diabetic retinopathy – associated inner retinal abnormalities in the mouse STZ model.

Authors: Ragauskas S, et al.

All ARVO 2023 abstracts:
https://t.co/7FiTU1lfk0

#Experimentica #Event

[Experimentica @experimentica]

[ABSTRACT] Efficacy of topical ketotifen and prednisolone in the rabbit 48/80 model for allergic conjunctivitis.

Authors: Pappenhagen NE, et al.

All ARVO 2023 abstracts:
https://t.co/7FiTU1lfk0

#Experimentica #Event

[Experimentica @experimentica]

[PRESS RELEASE] Experimentica Ltd. Announces Strategic Expansion of Management Team with Three Key Appointments

This will bolster Experimentica’s Leadership team, driving Innovation and growth in preclinical ocular models

Full PR:
https://t.co/FRTmu4MbEN

#Experimentica

[Experimentica @experimentica]

[ABSTRACT] AAV-mediated expression of human VEGF-A as a novel rat model of diabetic retinopathy.

Authors: Lelyte I, et al.

All ARVO 2023 abstracts:
https://t.co/7FiTU1lfk0

#Experimentica #Event

[Experimentica @experimentica]

[ABSTRACT] Involvement of thioredoxin system in laser-induced CNV mouse model.

Authors: Cesna R, et al.

All ARVO 2023 abstracts:
https://t.co/7FiTU1lfk0

#Experimentica #Event

[Experimentica @experimentica]

[ABSTRACT] Environmental particulate matter of different sizes leads to differential damage of the ocular surface.

Authors: Ghosh AK, et al.

All ARVO 2023 abstracts:
https://t.co/7FiTU1lfk0

#Experimentica #Event